B
Bull
Bull · 25%RBOT
$13.68
Precio del escenario
$1.920
-0.113 (-5.88%)Al cierre
Loading chart…
- High
- 2.080
- Open
- 1.990
- VWAP
- 1.97
- Vol
- 53.79K
- Mkt Cap
- 40.98M
- Low
- 1.920
- Amount
- 106.14K
- EV/EBITDA, TTM
- -0.55
Vicarious Surgical Inc. is a robotics company, developing technology to improve surgical procedures. The Company is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.
AI analysis of Vicarious Surgical Inc (RBOT)
holdVicarious Surgical Inc (RBOT) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive financial performance, absence of trading trends, and no significant news or catalysts make it a hold. The technical indicators are neutral, and there are no proprietary trading signals to suggest immediate action.
Métricas de valoración
The current forward P/E ratio for Vicarious Surgical Inc (RBOT) is -0.52, compared to its 5-year average forward P/E of -4.63.
Alphio AI Price Scenarios for RBOT
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding RBOT
Cronología de eventos
Noticias
3.505-13NewsfilterVicarious Surgical Completes Synthetic Abdominal Model Lab
- 9.504-30seekingalpha
Vicarious Surgical Reports Q1 Financial Results
- 9.504-30Newsfilter
Vicarious Surgical Reports Significant Improvement in Q1 Financials
- 8.503-30Newsfilter
Vicarious Surgical Completes Surgical Instrument Testing
- 8.503-25Newsfilter
Vicarious Surgical Receives Approval for OTCQB Listing
RBOT FAQ — answered by Alphio AI
Vicarious Surgical Inc. is a robotics company, developing technology to improve surgical procedures. The Company is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Vicarious Surgical Inc (RBOT) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive financial performance, absence of trading trends, and no significant news or catalysts make it a hold. The technical indicators are neutral, and there are no proprietary trading signals to suggest immediate action.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.